A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Drugs in R&D

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2165/00126839-200809030-00001PMID 18457466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase 1B, randomized, double‐blind, dose‐escalation trial of CPG 10101 in patients with chronic hepatitis C virus

  2007cited by this paper
• Adjuvant Effect of CpG‐Oligodeoxynucleotide in Anti‐Fungal Chemotherapy against Fatal Infection with Cryptococcus neoformans in Mice

  2007cited by this paper
• Antiinfective applications of toll-like receptor 9 agonists.

  2007cited by this paper
• 730 Early viral response to CPG 10101, in combination with pegylated interferon and/or ribavirin, in chronic HCV genotype 1 infected patients with prior relapse response

  2006cited by this paper
• Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.

  2006cited by this paper
• CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults

  2005cited by this paper
• Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells

  2005cited by this paper
• Toll-like receptors. I. Structure, function and their ligands.

  2005cited by this paper
• Global Epidemiology of Hepatitis B Virus

  2004cited by this paper
• CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study

  2004cited by this paper
• Global burden of disease (GBD) for hepatitis C

  2004cited by this paper
• Global Burden of Disease (GBD) for Hepatitis C

  2004cited by this paper
• Toll-like receptor downstream signaling

  2004cited by this paper
• Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.

  2004cited by this paper
• Biological activity of immunostimulatory CpG DNA motifs in domestic animals.

  2003cited by this paper
• Toll-like receptors.

  2003cited by this paper
• A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.

  2003cited by this paper
• CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection1

  2003cited by this paper
• T Helper 2 Immunity to Hepatitis B Surface Antigen Primed by Gene‐Gun‐Mediated DNA Vaccination can be Shifted Towards T helper 1 Immunity by Codelivery of CpG Motif‐Containing Oligodeoxynucleotides

  2003cited by this paper
• CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice

  2003cited by this paper
• Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks.

  2001cited by this paper
• CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.

  2001cited by this paper
• Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

  2001cited by this paper
• Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2001cited by this paper
• Enhancing vaccines with immune stimulatory CpG DNA.

  2001cited by this paper
• The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides

  2000cited by this paper
• CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans.

  2000cited by this paper
• Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo1

  2000cited by this paper
• Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2000cited by this paper
• Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.

  1999cited by this paper
• Immunostimulatory CpG Motifs Trigger a T Helper-1 Immune Response to Human Immunodeficiency Virus Type-1 (HIV-1) gp160 Envelope Proteins

  1999cited by this paper
• A family of human receptors structurally related to Drosophila Toll.

  1998cited by this paper
• Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans.

  1998cited by this paper
• Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness.

  1997cited by this paper
• A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

  1997cited by this paper
• Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers

  1997cited by this paper
• T1/ST2 Signaling Establishes It as a Member of an Expanding Interleukin-1 Receptor Family (*)

  1996cited by this paper
• The immunogenicity of influenza virus vaccine in solid organ transplant recipients.

  1996cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• The Efficacy of Influenza Vaccine in Elderly Persons

  1995cited by this paper
• Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.

  1994cited by this paper
• The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.

  1994cited by this paper
• Complement Activation and Hemodynamic Changes Following Intravenous Administration of Phosphorothioate Oligonucleotides in the Monkey

  1994cited by this paper
• Prevention and control of influenza: Role of vaccine

  1987cited by this paper
• Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982.

  1983cited by this paper
• Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths.

  1980cited by this paper
• Antigenic drift and efficacy of influenza virus vaccines, 1976--1977.

  1978cited by this paper
• Influenza in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain.

  1974cited by this paper

• Novel rabies vaccine candidates development based on pseudotyped lentiviral vectors with rabies virus glycoprotein

  2025cites this paper
• The Pivotal Role of Irradiation-induced Autophagy Mechanisms in Glioma Therapy.

  2025cites this paper
• Endosomal Toll-Like Receptors intermediate negative impacts of viral diseases, autoimmune diseases, and inflammatory immune responses on the cardiovascular system

  2024cites this paper
• The main groups of adjuvants and the prospects of their use for the specific prevention of particularly dangerous and other infectious diseases

  2023cites this paper
• Viral T-cell epitopes - Identification, characterization and clinical application.

  2023cites this paper
• Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial

  2023cites this paper
• Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review

  2022cites this paper
• TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target

  2021cites this paper
• Carrier-free micellar CpG interacting with cell membrane for enhanced immunological treatment of HIV-1.

  2021cites this paper
• Modulating Immune Response with Nucleic Acid Nanoparticles

  2019cites this paper
• Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B

  2018cites this paper
• Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections

  2018cites this paper
• Immunological Efficacy and Safety of Synthesized CpG Oligodeoxynucleotides

  2018cites this paper
• Genital warts treatment: Beyond imiquimod

  2018cites this paper
• Immunological Efficacy and Safety of Synthesized CpG Oligodeoxynucleotides

  2018cites this paper
• The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.

  2018cites this paper
• Viral life cycle of hepatitis B virus: Host factors and druggable targets

  2016cites this paper
• Impact of in vitro Costimulation with TLR2, TLR4 and TLR9 Agonists and HIV-1 on Antigen-Presenting Cell Activation

  2015cites this paper
• Glioma

  2015cites this paper
• Maximal immune response and cross protection by influenza virus nucleoprotein derived from E. coli using an optimized formulation.

  2014cites this paper
• Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits.

  2014cites this paper
• Inactivated vaccine with adjuvants consisting of pattern recognition receptor agonists confers protection against avian influenza viruses in chickens.

  2014cites this paper
• Innate immune responses of salmonid fish to viral infections.

  2014cites this paper
• Therapeutic vaccines explored in patients with non-small cell lung cancer.

  2014cites this paper
• Parenteral administration of GnRH constructs and adjuvants: immune responses and effects on reproductive tissues of male mice.

  2014cites this paper
• Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health

  2013cites this paper
• The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry.

  2013cites this paper
• Prostate cancer vaccines

  2013cites this paper
• Role of innate immunity in the development of hepatocellular carcinoma.

  2013cites this paper
• TLR Agonists as Vaccine Adjuvants

  2012cites this paper
• Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.

  2012cites this paper
• Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections

  2012cites this paper
• Sterile inflammation in the liver.

  2012cites this paper
• Formulation and delivery of vaccines: Ongoing challenges for animal management

  2012cites this paper
• Innovation in Vaccinology

  2012cites this paper
• Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant glioma.

  2012cites this paper
• Cellules dendritiques plasmocytoïdes et infections virales : rôle physiopathologique et potentiel vaccinal

  2012cites this paper
• Novel regulatory functions for Toll‐like receptor‐activated B cells during intracellular bacterial infection

  2011cites this paper
• Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy

  2011cites this paper
• Addition of the Immunostimulatory Oligonucleotide IMT504 to a Seasonal Flu Vaccine Increases Hemagglutinin Antibody Titers in Young Adult and Elder Rats, and Expands the Anti-Hemagglutinin Antibody Repertoire

  2011cites this paper
• Targeting of Toll-like receptors: a decade of progress in combating infectious diseases.

  2011cites this paper
• Non-small-cell lung carcinoma vaccines in clinical trials

  2011cites this paper
• Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen

  2011cites this paper
• The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant.

  2010cites this paper
• Bioinformatics in New Generation Flavivirus Vaccines

  2010cites this paper
• A High Dose of IMT504, the PyNTTTTGT Prototype Immunostimulatory Oligonucleotide, Does Not Alter Embryonic Development in Rats

  2010cites this paper
• All three classes of CpG ODNs up-regulate IP-10 gene in pigs.

  2010cites this paper
• Mucosally delivered peptides prime strong immunity in HLA-A2.1 transgenic rabbits.

  2010cites this paper
• EXPRESSÃO E PURIFICAÇÃO DE DUAS FORMAS QUIMÉRICAS DAS PROTEÍNAS Sm29 E SmTSP-2 DO SCHISTOSOMA MANSONI E

  2010cites this paper
• Scientific Opinion on the assessment of allergenicity of GM plants andmicroorganisms and derived food and feed

  2010cites this paper
• Adjuvant guided T cell responses.

  2009cites this paper
• Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

  2009cites this paper
• Immunoregulation of GVHD by triggering the innate immune system with CpG

  2009cites this paper
• Neonate Intestinal Immune Response to CpG Oligodeoxynucleotide Stimulation

  2009cites this paper
• The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents

  2009cites this paper
• CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.

  2009cites this paper
• CpG Oligodeoxynucleotides Activate Innate Immune Response that Suppresses Infectious Bronchitis Virus Replication in Chicken Embryos

  2009cites this paper
• Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.

  2009cites this paper
• Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.

  2009cites this paper
• CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.

  2009cites this paper
• Managing hepatitis C in liver transplant patients with recurrent infection

  2009cites this paper
• Encephalitogenicity of Complete Freund’s Adjuvant Relative to CpG Is Linked to Induction of Th17 Cells

  2009cites this paper
• Induction of Th17 Cells Adjuvant Relative to CpG Is Linked to Encephalitogenicity of Complete Freund's

  2009cites this paper
• This information is current as Induction of Th 17 Cells Adjuvant Relative to CpG Is Linked to Encephalitogenicity of Complete Freund ' s

  2009cites this paper
• The effects of topical calcipotriol treatment on immune responses to vaccination

  2008influential citation